Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
05/2012
05/24/2012CA2817165A1 Novel antiviral compounds
05/23/2012CN102471341A Compounds and compositions for the treatment of parasitic diseases
05/23/2012CN102471335A Azabicyclo compound and salt thereof
05/23/2012CN102464670A 一种长春花高含量抗癌生物碱制备方法 One kind of vinca alkaloids high levels of anti-cancer preparation
05/22/2012US8183375 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/17/2012US20120122804 Substituted quinobenzoxazine analogs
05/17/2012US20120121540 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections
05/16/2012EP2453496A1 Organic electroluminescent element, novel compound, lighting device and display device
05/16/2012EP2451814A2 Fused imidazoles and compositions comprising them for the treatment of parasitic diseases, such as e.g. malaria
05/16/2012EP2451812A1 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
05/16/2012CN102459251A 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物 Compound bicyclic heteroaryl moiety having two fused leukotriene a4 hydrolase as modulators of
05/16/2012CN102459249A 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxazepine cycloheptatriene and their use and manufacturing method
05/16/2012CN102453044A Method for preparing biapenem by using micro-reaction technology
05/15/2012US8178541 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
05/10/2012WO2011031818A3 Histamine h3 inverse agonists and antagonists and methods of use thereof
05/10/2012US20120114599 Opioid and opioid-like compounds and uses thereof
05/09/2012EP1423107B1 Fatty alcohol drug conjugates
05/09/2012CN102448961A Dihydro) imidazoiso (5, 1-A) quinolines as fsh receptor agonists for the treatment of fertility disorders
05/09/2012CN102443017A Preparation method of cefozopran hydrochloride
05/09/2012CN102443016A Method for preparing cefozopran hydrochloride intermediate
05/09/2012CN102443015A 7-substituted quinoline carboxylic acid derivatives, preparation method and application thereof in antibiosis and antituberculosis
05/09/2012CN101812079B Piprazine compound containing polysulfide bond and preparation method and application thereof
05/03/2012WO2012056904A1 Organic electroluminescent element and light-emitting device
05/03/2012WO2012056372A1 N1/N2-LACTAM ACETYL-CoA CARBOXYLASE INHIBITORS
05/03/2012WO2012055888A1 Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists
05/03/2012US20120108596 Aza-Bicyclic Amine N-Oxide Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligand Pro-Drugs
05/03/2012CA2815169A1 N1/n2-lactam acetyl-coa carboxylase inhibitors
05/02/2012EP2445346A1 Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
05/02/2012EP2053051B1 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
05/02/2012EP1756120B1 Purine derivative
05/02/2012EP1415992B1 Diamine derivatives
05/02/2012CN102439015A 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/02/2012CN102439008A 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
05/02/2012CN102432630A Method for extracting dehydrated vinblastine and epoxy vinblastine from fresh grass of catharanthus roseus
05/01/2012US8168654 Quinuclidine derivatives binding to mucarinic M3 receptors
05/01/2012US8168647 Vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives
05/01/2012US8168622 β-lactamase-resistant cephalosporin ester compounds and salts of thereof
05/01/2012CA2490722C Novel benzimidazole derivatives
04/2012
04/26/2012WO2012053398A1 Organic electroluminescent element
04/25/2012EP2444120A1 Spirocyclic amiloride analogues as ENac blockers
04/25/2012EP1482933B1 Potent, simplified derivatives of immunosuppressive agents
04/25/2012CN102424681A Acyl-tetrahydro-beta-carboline compound as well as derivatives, application and preparation method thereof
04/24/2012US8163736 Cytotoxic agents comprising new tomaymycin derivatives
04/24/2012US8163479 Specific substrates for O6-alkylguanine-DNA alkyltransferase
04/19/2012WO2012050003A1 Organic electroluminescent element
04/19/2012WO2012050002A1 Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device
04/19/2012US20120095213 Cinnamido-pyrrolo[2,1-c][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof
04/18/2012CN102417585A Organic semiconductor material containing dithienothiophene and thienopyrryldiketone units, and preparation method and application thereof
04/17/2012US8158622 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
04/17/2012CA2593428C Pyrrolopyrazoles, potent kinase inhibitors
04/12/2012US20120088312 Vincristine immunoassay
04/12/2012US20120085995 Material for organic electroluminescence device and organic electroluminescence device using the same
04/11/2012EP2438067A1 New compounds
04/11/2012EP1532153B8 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
04/10/2012US8153652 Fab I inhibitors
04/10/2012CA2634646C Pyrimidine derivatives for the treatment of abnormal cell growth
04/10/2012CA2549147C Tricyclic 1-((3-indol-3-yl)carbonyl) piperazine derivatives as cannabinoid cb1 receptor agonists
04/05/2012WO2012041849A1 Semiconductors based on diketopyrrolopyrroles
04/05/2012WO2011032050A3 Gyrase inhibitors
04/04/2012EP2436679A1 Anthracene derivative and organic electroluminescent element using the same
04/04/2012EP2435433A1 (dihydro) imidazoiso (5, 1-a) quinolines as fsh receptor agonists for the treatment of fertility disorders
04/04/2012EP2435046A1 Heterocyclic compounds for the treatment of stress-related conditions
04/04/2012EP2434889A1 Iap inhibitors
04/04/2012EP2434888A1 Ketal esters of anhydropentitols and uses thereof
04/04/2012EP2434885A1 Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
04/04/2012EP1990343B1 Azaindoles
04/04/2012CN102399233A PI3K和mTOR双重抑制剂类化合物 PI3K and mTOR dual inhibitor compounds
04/04/2012CN102399220A 三并环类PI3K和mTOR双重抑制剂 Three and ring type PI3K and mTOR dual inhibitors
04/04/2012CN102399218A 一类并合三杂环及其作为pi3k抑制剂的用途 A class of merging three heterocyclic inhibitors and their use as pi3k
04/04/2012CN101921238B 取代苯并氮杂环类衍生物的制备及其药理用途 Benzazepine ring-substituted derivatives of preparation and pharmacological uses
04/03/2012US8148394 Azaindoles having serotonin receptor affinity
03/2012
03/29/2012WO2012039508A1 Pyrrolopyridine compound and use thereof
03/29/2012US20120077787 Organic compounds
03/28/2012EP2433943A1 Thienopyrazole derivatives having PDE7 inhibitory activity
03/28/2012EP2432779A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
03/28/2012EP2178878B1 Tetracyclic compounds for the treatment of hepatitis c
03/28/2012EP1956008B1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
03/28/2012EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/27/2012CA2682329C Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
03/22/2012WO2012036185A1 Metal complex, alteration product thereof, and compound useful in same
03/22/2012US20120070409 Tetracyclic fused heterocyclic compound and use thereof as hcv polymerase inhibitor
03/21/2012EP2431368A1 CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives
03/21/2012EP2431366A1 New chlorine e6-folic acid conjugated compound, preparation method thereof, and pharmaceutical composition containing the same for treatment of cancer
03/21/2012EP2430031A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
03/21/2012EP2430027A1 Triazole/tetrazole polymers resulting from the cycloaddition of functionalized monomers derived from dianhydrohexitol, intermediate compounds, methods of preparing same and applications thereof
03/21/2012EP2430022A1 1,2,3-triazolo ý4,3-a¨pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
03/21/2012EP2430019A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
03/21/2012EP2430013A1 Heteroaryl compounds as pikk inhibitors
03/21/2012EP2429290A1 Compounds and methods for treating aids and hiv infections
03/21/2012EP1771450B9 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
03/21/2012CN102382129A Spirocycles-substituted phosphodiesterase inhibitor
03/21/2012CN102382128A Three-ring fused PI3K and mTOR dual inhibitor
03/21/2012CN101437829B Bisadenosine compounds as adenosine A2A receptor agonists
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
03/15/2012WO2012033144A1 Pyrazoloquinoline compound
03/15/2012WO2012033101A1 Quinoxaline compound
03/15/2012US20120065402 Electronic device including phenanthroline derivative
03/15/2012US20120065190 Benzazepine compounds as cgrp receptor antagonists
03/15/2012US20120065149 Vitamin receptor binding drug delivery conjugates
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 111